Handelsbanken Fonder’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Handelsbanken Fonder’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,509	Closed	-$796K	–	1630
2023 Q3	$796K	Hold	18,509	–	–	﹤0.01%	814
2023 Q2	$780K	Sell	18,509 -500	-3%	-$20.2K	﹤0.01%	846
2023 Q1	$677K	Buy	19,009 +12,400	+188%	+$450K	﹤0.01%	854
2022 Q4	$242K	Sell	6,609 -8,500	-56%	-$336K	﹤0.01%	1356
2022 Q3	$712K	Hold	15,109	–	–	﹤0.01%	778
2022 Q2	$1.08M	Hold	15,109	–	–	0.01%	660
2022 Q1	$1.22M	Hold	15,109	–	–	0.01%	721
2021 Q4	$1.55M	Hold	15,109	–	–	0.01%	698
2021 Q3	$1.32M	Hold	15,109	–	–	0.01%	766
2021 Q2	$1.35M	Buy	15,109 +2,900	+24%	+$245K	0.01%	769
2021 Q1	$926K	Sell	12,209 -3,700	-23%	-$279K	0.01%	878
2020 Q4	$1.08M	Sell	15,909 -2,800	-15%	-$175K	0.01%	786
2020 Q3	$995K	Hold	18,709	–	–	0.01%	727
2020 Q2	$1.09M	Buy	+18,709	New	+$1.01M	0.01%	660

Other funds holding SYNH

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Handelsbanken Fonder's SYNH Position: Q4 2023 in Review

Handelsbanken Fonder sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2023, closing a stake of 18,509 shares — an estimated $796K sold.

Handelsbanken Fonder first reported a position in SYNH in Q2 2020 and held it in 14 quarters. The position peaked at $1.55M in Q4 2021. 2 funds tracked by Wall St. Rank hold SYNH as of Q4 2023.

Handelsbanken Fonder reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Handelsbanken Fonder sold 18,509 Syneos Health, Inc. Class A Common Stock shares in Q4 2023, an estimated $796K.
Handelsbanken Fonder first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 14 quarters.
Handelsbanken Fonder's Syneos Health, Inc. Class A Common Stock position peaked at $1.55M in Q4 2021.
2 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2023.

Based on Handelsbanken Fonder's 13F filing for Q4 2023, filed 1 Feb 2024.